Study Stopped
Lack of enrollment
Feasibility and Acceptability Study of ACUAWARE
ACUAWARE
Collecting Pragmatic Data Via Electronic Health Records: ACUAWARE Feasibility and Acceptability Study
1 other identifier
observational
1
1 country
1
Brief Summary
This study aims to gather preliminary feasibility and acceptability data to justify a subsequent trial that would fill a gap in knowledge regarding acupuncture therapy (AT) effects on interoceptive awareness (IA) among those with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2023
CompletedFirst Posted
Study publicly available on registry
November 24, 2023
CompletedStudy Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedMarch 24, 2025
March 1, 2025
10 months
November 12, 2023
March 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Feasibility metrics - rate of enrollment
Rate of enrollment of acupuncturists and patients (frequency count)
24 months
Feasibility metrics - rate of retention
Rate of retention of acupuncturists and participants (frequency count)
24 months
Feasibility metrics - rate of questionnaire completion
Rate of questionnaire completion by participants (frequency count)
24 months
Feasibility metrics - completion rate of acupuncture therapy
Rate of completion of acupuncture therapy (AT) (frequency count)
24 months
Feasibility metrics - rate of serious adverse events
Rate of serious adverse events (frequency count)
24 months
Acceptability metrics
Acceptability ratings by licensed acupuncturists and by participants. Acceptability is asked in a binary question: "Is it acceptable to you to use the Acu-Track registry?" Yes/No. We define "acceptable" as 70% or more of licensed acupuncturists to use Acu-Track Registry; and acceptable for 70% or more of patients to complete questionnaires emailed to them via Acu-Track Registry.
24 months
Secondary Outcomes (7)
Multidimensional Assessment of Interoceptive Awareness Scale, 2 (MAIA-2)
24 months
Global Impression of Change (GIC)
24 months
Physical Function from Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10)
24 months
Global Mental Health
24 months
Anxiety
24 months
- +2 more secondary outcomes
Study Arms (1)
Persons with chronic pain
Standard acupuncture care will be provided to persons (n=50) with chronic pain. Standard care is defined as the care a participant was already receiving and that care will not be interrupted in any way for any study participant.
Interventions
Acupuncture therapy (AT) is delivered by Licensed Acupuncturists (LAcs). Treatment plans are determined according to each patient's presentation and resulting traditional East Asian medicine (TEAM) differential diagnosis. TEAM therapeutics include AT, Chinese herbal medicine (CHM), Kampo herbal medicine, gua sha, tui na, cupping and lifestyle advice. All TEAM therapeutics are allowed in this study because it is a pragmatic, effectiveness study.
Eligibility Criteria
Adults in the United States with chronic pain, defined as pain lasting of 3 or more months, and given a score of 5 or greater on a 1-10 scale.
You may qualify if:
- Patients:
- Age 18 or older;
- experiencing chronic pain,
- complaint of 3+ months,
- score of 5 or greater on a 1-10 scale;
- able to provide informed consent
- willing to sign an approved consent form that conforms to federal and institutional guidelines,
- English speaking and writing.
You may not qualify if:
- Prior or current diagnosis of:
- cancer,
- Multiple Sclerosis (MS),
- any Dementia,
- Parkinson's Disease,
- Autism Spectrum Disorder,
- Pregnancy,
- Fibromyalgia,
- Eating Disorder,
- Down's Syndrome
- Schizophrenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Pace Universitycollaborator
Study Sites (1)
University of Utah College of Nursing
Salt Lake City, Utah, 84112, United States
Related Publications (4)
Chou R, Deyo R, Friedly J, Skelly A, Hashimoto R, Weimer M, Fu R, Dana T, Kraegel P, Griffin J, Grusing S, Brodt ED. Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017 Apr 4;166(7):493-505. doi: 10.7326/M16-2459. Epub 2017 Feb 14.
PMID: 28192793BACKGROUNDDi Lernia D, Serino S, Riva G. Pain in the body. Altered interoception in chronic pain conditions: A systematic review. Neurosci Biobehav Rev. 2016 Dec;71:328-341. doi: 10.1016/j.neubiorev.2016.09.015. Epub 2016 Sep 18.
PMID: 27654341BACKGROUNDGrissa MH, Baccouche H, Boubaker H, Beltaief K, Bzeouich N, Fredj N, Msolli MA, Boukef R, Bouida W, Nouira S. Acupuncture vs intravenous morphine in the management of acute pain in the ED. Am J Emerg Med. 2016 Nov;34(11):2112-2116. doi: 10.1016/j.ajem.2016.07.028. Epub 2016 Jul 20.
PMID: 27475042BACKGROUNDTeng B, Wang D, Su C, Zhou H, Wang T, Mehling WE, Hu Y. The multidimensional assessment of interoceptive awareness, version 2: Translation and psychometric properties of the Chinese version. Front Psychiatry. 2022 Nov 11;13:970982. doi: 10.3389/fpsyt.2022.970982. eCollection 2022.
PMID: 36440402BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa J Taylor-Swanson, PHD
University of Utah College of Nursing
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2023
First Posted
November 24, 2023
Study Start
December 15, 2023
Primary Completion
October 15, 2024
Study Completion
October 15, 2024
Last Updated
March 24, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
No individual participant data (IPD) will be used or received in this study, thus no IPD can be made available to other researchers.